TrialClinical cancer research : an official journal of the American Association for Cancer Research2018

Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.

Maki Tanioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.